Clinical trial
Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women
NCT00102986 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00102986 |
|---|---|
| Title | Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women |
| Official title | Sex Differences in Lopinavir/Ritonavir Pharmacokinetics Among HIV-1-Infected Men and Women |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Lopinavir/ritonavir |
| Enrollment | 116 |
| Start date | Oct 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Feb 7, 2005 |
| Last update posted | Dec 3, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: